[1] Knight PG, Glister C. Local roles ofTGF-β superfamily members in the control of ovarian follicle development [J]. Anim Reprod Sci, 2003, 78(3-4): 165-83. [2] Padgett RW, Cho SH, Evangelista C. Smads are the central com ponent in transforming growth factor-β signaling [J]. PharmacolTher, 1998, 78(1): 47-52. [3] Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC 4as a central mediator of Smad function [J]. Curr Biol, 1997, 7(4): 270-6. [4] 申洪.免疫组织化学染色定量方法的研究(Ⅲ)[J]中国组织化学与细胞杂志,1995,4(1):89-92.Hong S. Study on the quantitative method of immunohistochemistry [J]. Chin J Histochem Cytochem, 1995, 4(1): 89-92. [5] Findlay JK, Drummond AE, Dyson M, et al. Production and actions of inhibin and activin during folliculogenesis in the rat [J]. Mol Cell Endocrinol, 2001, 180(1-2): 139-44. [6] Glister C, Kemp CF, Knight PG, et al. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4,-6 and-7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin [J]. Reproduction, 2004, 127(2): 239-54. [7] Mazerbourg S, Hsueh AJW. Growth differentiation factor-9 signa ling in the ovary[J]. Mol Cell Endocrinol, 2003, 202(1-2): 31-6. [8] Zimmerman CM, Padgett RW. Transforming growth factor β sig naling mediators and modulators[J]. Gene, 2000, 249(1-2): 17-30. [9] Fukami K, Ueda S, Yamagishi S, et al. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin Ⅱ type Ⅰ receptor interaction[J]. Kidney Iht, 2004, 66(6): 2137-47. [10] Findlay JK, Drummond AE, Dyson M, et al. Recruitment and development of the follicle: the roles of the transforming growth factor-β superfamily[J]. Mol Cell Endocrinol, 2002, 191(1): 35-43. [11] Chang WY, Shidaifat F, Uzumcu M, et al. Effects of transforming growth factor-β1 and activin-A on in vitro porcine granulosa cell steroidogenesis [J]. Theriogenology, 1996, 45(8): 1463-72. [12] Pehlivan T, Mansour A, Spaczyski RZ, et al. Effects of transforminggrowth factors-alpha and-beta on proliferation and apoptosis of rat theca-interstitial cells [J]. J Endocrinol, 2001, 170(3): 639-45. [13] 葛明晓,李红,邢福祺,等卵泡液中TGFβ1和性激素水平的测定及临床意义[J].第一军医大学学报,2003,23(5):463-5.Ge MX, Li H, Xing FQ, et al. Transforming growth factor-β1, estradiol, progesterone and lutropin levels in follicular fluid after ovarian stimulation[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(5): 463-5. [14] Calabrese F, Valente M, Giacometti C, et al. Parenchymal transforming growth factor beta-l: its type Ⅱ receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology [J]. J Gastroenterol Hepatol, 2003, 18 ( 11): 1302-8. [15] Akhurst R J, Derynck Rk. TGF-β signaling in cancer-a double-edged sword[J]. Trends Cell Biol, 2001, 11(11): S44-51. [16] Longerich T, Breuhahn K, Odenthal M, et al. Factors of transfor ming growth factor beta signalling are co-regulated in human hepatocellular carcinoma[J]. Virchows Arch, 2004, 445(6): 589-96. [17] Reinacher-Schick A, Baldus SE, Romdhana B, et al. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas [J]. J Pathol, 2004, 202(4): 412-20. |